Drug
Iloperidone Crystalline Formulation
Iloperidone Crystalline Formulation: highest development phase Phase 1/2, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Iloperidone crystalline formulation NCT01348100 | Phase 1/2 | Schizophrenia |
Latest
No recent events.
Follow Iloperidone Crystalline Formulation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.